Free Trial

Bwcp LP Has $17.39 Million Stock Holdings in Axon Enterprise, Inc $AXON

Axon Enterprise logo with Aerospace background

Key Points

  • Bwcp LP increased its holdings in Axon Enterprise, Inc by 10.2% during the first quarter, owning 33,070 shares valued at approximately $17.39 million.
  • A number of analysts have raised their price targets for Axon Enterprise, with Bank of America setting a target of $1,000.00, indicating strong bullish sentiment towards the stock.
  • CEO Patrick W. Smith sold 10,000 shares of Axon Enterprise stock recently, reducing his ownership by 0.33% in a transaction valued at over $8.3 million.
  • Five stocks we like better than Axon Enterprise.

Bwcp LP boosted its holdings in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 10.2% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 33,070 shares of the biotechnology company's stock after acquiring an additional 3,072 shares during the quarter. Axon Enterprise accounts for 3.5% of Bwcp LP's portfolio, making the stock its 17th largest position. Bwcp LP's holdings in Axon Enterprise were worth $17,393,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. TCTC Holdings LLC increased its position in shares of Axon Enterprise by 75.0% during the 1st quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company's stock valued at $29,000 after purchasing an additional 24 shares during the period. Fourth Dimension Wealth LLC acquired a new position in shares of Axon Enterprise during the 4th quarter valued at $30,000. Bartlett & CO. Wealth Management LLC increased its position in shares of Axon Enterprise by 132.0% during the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company's stock valued at $31,000 after purchasing an additional 33 shares during the period. Banque Transatlantique SA acquired a new position in shares of Axon Enterprise during the 1st quarter valued at $31,000. Finally, Catalyst Capital Advisors LLC acquired a new position in shares of Axon Enterprise during the 1st quarter valued at $32,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, CEO Patrick W. Smith sold 10,000 shares of the business's stock in a transaction that occurred on Monday, August 11th. The stock was sold at an average price of $831.29, for a total value of $8,312,900.00. Following the transaction, the chief executive officer directly owned 3,053,982 shares of the company's stock, valued at $2,538,744,696.78. The trade was a 0.33% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, President Joshua Isner sold 15,919 shares of the business's stock in a transaction that occurred on Friday, August 15th. The stock was sold at an average price of $746.26, for a total transaction of $11,879,712.94. Following the completion of the transaction, the president owned 238,379 shares of the company's stock, valued at $177,892,712.54. This trade represents a 6.26% decrease in their position. The disclosure for this sale can be found here. Insiders sold 34,865 shares of company stock worth $26,926,433 over the last ninety days. 4.40% of the stock is owned by insiders.

Axon Enterprise Stock Down 0.2%

NASDAQ AXON traded down $1.75 during trading on Friday, hitting $728.41. 398,045 shares of the company traded hands, compared to its average volume of 544,125. The company has a current ratio of 2.95, a quick ratio of 2.71 and a debt-to-equity ratio of 0.63. The business has a fifty day simple moving average of $765.93 and a 200 day simple moving average of $679.57. The company has a market capitalization of $57.18 billion, a P/E ratio of 179.85, a PEG ratio of 26.73 and a beta of 1.40. Axon Enterprise, Inc has a 12 month low of $346.71 and a 12 month high of $885.91.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last issued its quarterly earnings results on Monday, August 4th. The biotechnology company reported $2.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.54 by $0.58. The firm had revenue of $668.54 million for the quarter, compared to analyst estimates of $641.77 million. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The company's quarterly revenue was up 32.6% compared to the same quarter last year. During the same period in the previous year, the company posted $1.20 earnings per share. Axon Enterprise has set its FY 2025 guidance at EPS. As a group, sell-side analysts predict that Axon Enterprise, Inc will post 5.8 EPS for the current year.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on AXON. Morgan Stanley set a $885.00 target price on Axon Enterprise and gave the stock an "overweight" rating in a report on Friday, July 11th. Wolfe Research began coverage on Axon Enterprise in a report on Monday, July 7th. They issued an "outperform" rating on the stock. Raymond James Financial restated an "outperform" rating and issued a $855.00 target price (up from $645.00) on shares of Axon Enterprise in a report on Tuesday, August 5th. JMP Securities lifted their target price on Axon Enterprise from $725.00 to $825.00 and gave the stock a "market outperform" rating in a report on Tuesday, July 22nd. Finally, Zacks Research cut Axon Enterprise from a "strong-buy" rating to a "hold" rating in a report on Tuesday, September 2nd. Thirteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $837.69.

Check Out Our Latest Stock Report on Axon Enterprise

Axon Enterprise Profile

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Read More

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Should You Invest $1,000 in Axon Enterprise Right Now?

Before you consider Axon Enterprise, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.

While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Inside Retail: Where Smart Investors See the Upside
Not All AI Stocks Are Done — 4 With Huge Growth Ahead
The Quantum Race: 4 Companies Competing for the Future

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines